Acute and post-acute COVID-19 cardiovascular complications: a comprehensive review
C Kole, Ε Stefanou, N Karvelas, D Schizas… - … drugs and therapy, 2023 - Springer
Abstract Purpose of Review The risk of cardiovascular complications due to SARS-CoV-2
are significantly increased within the first 6 months of the infection. Patients with COVID-19 …
are significantly increased within the first 6 months of the infection. Patients with COVID-19 …
Aloin isoforms (A and B) selectively inhibits proteolytic and deubiquitinating activity of papain like protease (PLpro) of SARS-CoV-2 in vitro
DSM Lewis, J Ho, S Wills, A Kawall, A Sharma… - Scientific reports, 2022 - nature.com
The most common host entry point of human adapted coronaviruses (CoV) including SARS-
CoV-2 is through the initial colonization in the nostril and mouth region which is responsible …
CoV-2 is through the initial colonization in the nostril and mouth region which is responsible …
[HTML][HTML] Mast cell activation is associated with post‐acute COVID‐19 syndrome
JB Wechsler, M Butuci, A Wong, AP Kamboj… - Allergy, 2022 - ncbi.nlm.nih.gov
To the Editor, As of July 2021, over 30-million Americans have recovered from documented
COVID-19 infection, and prevalence studies suggest up to twice as many may be …
COVID-19 infection, and prevalence studies suggest up to twice as many may be …
Functions of double‐negative B cells in autoimmune diseases, infections, and cancers
Most mature B cells can be divided into four subtypes based on the expression of the
surface markers IgD and CD27: IgD+ CD27− naïve B cells, IgD+ CD27+ unswitched memory …
surface markers IgD and CD27: IgD+ CD27− naïve B cells, IgD+ CD27+ unswitched memory …
[HTML][HTML] Forsythiaside A alleviates acute lung injury by inhibiting inflammation and epithelial barrier damages in lung and colon through PPAR-γ/RXR-α complex
J Wang, X Xue, X Zhao, L Luo, J Liu, S Dai… - Journal of Advanced …, 2024 - Elsevier
Introduction Acute lung injury (ALI) is a lung disease characterized by inflammation and still
requires further drug development. Forsythiaside A as the active compound of Forsythiae …
requires further drug development. Forsythiaside A as the active compound of Forsythiae …
Dengue and COVID-19: two sides of the same coin
Abstract Background Many countries in Asia and Latin America are currently facing a double
burden of outbreaks due to dengue and COVID-19. Here we discuss the similarities and …
burden of outbreaks due to dengue and COVID-19. Here we discuss the similarities and …
The NSP4 T492I mutation increases SARS-CoV-2 infectivity by altering non-structural protein cleavage
X Lin, Z Sha, J Trimpert, D Kunec, C Jiang, Y Xiong… - Cell Host & Microbe, 2023 - cell.com
The historically dominant SARS-CoV-2 Delta variant and the currently dominant Omicron
variants carry a T492I substitution within the non-structural protein 4 (NSP4). Based on in …
variants carry a T492I substitution within the non-structural protein 4 (NSP4). Based on in …
[HTML][HTML] Multisystem inflammatory syndrome and autoimmune diseases following COVID-19: molecular mechanisms and therapeutic opportunities
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome-
coronavirus 2 (SARS-CoV-2) has led to huge concern worldwide. Some SARS-CoV-2 …
coronavirus 2 (SARS-CoV-2) has led to huge concern worldwide. Some SARS-CoV-2 …
Mitigation of influenza-mediated inflammation by immunomodulatory matrix-bound nanovesicles
RJ Crum, BR Huckestien, G Dwyer, L Mathews… - Science …, 2023 - science.org
Cytokine storm describes a life-threatening, systemic inflammatory syndrome characterized
by elevated levels of proinflammatory cytokines and immune cell hyperactivation associated …
by elevated levels of proinflammatory cytokines and immune cell hyperactivation associated …
Biomarkers during COVID-19: Mechanisms of change and implications for patient outcomes
As the COVID-19 (Coronavirus disease 19) pandemic spreads worldwide, the massive
numbers of COVID-19 patients have created a considerable healthcare burden for every …
numbers of COVID-19 patients have created a considerable healthcare burden for every …